Reduced RT Feasible in Chemo-Sensitive HPV-Associated Head and Neck Cancer

Patients with human papillomavirus –associated head and neck cancers who respond well to induction therapy can receive substantially lower doses of radiation and still achieve good safety and efficacy outcomes, according to a new phase II trial.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Head & Neck Cancer News Radiation Oncology Source Type: news